👏👏 congrats Karl Semaan, MD, MSc and team!! …and great soccer player!⚽️🥅🏆

SCLC transformation in #EGFR mutant NSCLC likely underdiagnosed - requires tissue biopsy but can liquid biopsy help? Novel epigenomic cfDNA approach Clinical Cancer Research shows uses histone modification to distinguish histologies. Very promising approach! aacrjournals.org/clincancerres/…

Radiological tumor burden, if shown to have a good prognostic role be easily calculable, could be used in pre-first-line immunotherapy assessment in metastatic clear cell renal cell carcinoma. #kicsm | Rashad Nawfal, MD KidneyCAN cancernetwork.com/view/radiologi…

Day made thanks to ASCO TECAG ASCO for providing a platform for young trainees at #ASCO24 as we presented our work from Yale Internal Medicine Yale Cancer Center Paul Stockhammer Michael Grant! Fernando Diaz, MD Jacob J. Adashek, DO

After adjuvant immunotherapy what comes next in RCC? Check out our work in European Urology as we try to answer some of the questions in this evolving field! Thread by Karl Semaan, MD, MSc below. A special thanks to our collaborators and Toni Choueiri, MD Daniel Heng for the mentorship & support!

Liquid biopsy in renal cell carcinoma | The Oncologist | with Marc Machaalani Karl Semaan, MD, MSc Marc Eid Rashad Nawfal, MD Razane El Hajj Chehade Sylvan Baca MD PhD (Hiring!) from Dana-Farber Lank Center for Genitourinary Oncology academic.oup.com/oncolo/advance…

Understanding #KEYNOTE564: Pembrolizumab’s role and post-adjuvant therapy for #RCC patients. Karl Semaan, MD, MSc & Talal El Zarif, MD join Zach Klaassen in this discussion of the evolving landscape in RCC treatment. #WatchNow > bit.ly/4e1l9mN Dana-Farber

🩸🧬Liquid biopsy is transforming cancer detection and monitoring, offering noninvasive insights. Recent studies show that ctDNA levels correlate with outcomes in RCC. Could emerging technologies enhance this? Marc Machaalani Karl Semaan, MD, MSc Marc Eid Rashad Nawfal, MD Razane El Hajj Chehade

🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org

A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman, the new David Goldstein Chair Dana-Farber. The Chair will focus on many aspects of Kidney Cancer Research Dana-Farber Lank Center for Genitourinary Oncology